Brief news reports on Tuberculosis

UI receives three grants to hasten discovery of new TB therapeutics

Forty-five years. That's how long it's been since the last drug - rifampin - hit the market to treat tuberculosis, an infection that affects nearly one third of the world's population and causes 1.8 million deaths annually.

Read More →

Human Immunity to Tuberculosis conference to take place from April 13-14

Leading international experts in tuberculosis and related diseases from at least 10 countries will gather at a Human Immunity to Tuberculosis conference April 13-14 in Atlanta. The meeting will take place at the Emory Conference Center, 1615 Clifton Rd., Atlanta, GA 30329.

Read More →

Ban urges countries to step up efforts to stop tuberculosis

22 March 2012 – Secretary-General Ban Ki-moon today urged countries to step up their efforts to prevent tuberculosis (TB), including by increasing access to treatments and improving the quality of their health services to be able to “stop TB in our lifetime.”

Read More →

UNITAID: World TB Day 2012

UNITAID has made a name for itself by creating the market for child-friendly HIV medicines but did you know it is also one of the world’s largest funders of tuberculosis (TB) medicines for kids?

Read More →

UNAIDS: World TB Day 2012

On World TB Day, let’s celebrate a partnership, which in just a few years is helping to transform the AIDS epidemic.

Read More →

World TB Day: Children with tuberculosis being failed

Much more needs to be done to prevent tuberculosis (TB) which affects at least half a million of the world’s children every year, with as many as 70 000 losing their lives. According to WHO and the Stop TB Partnership, most children can be saved from this curable illness with better diagnosis of the condition, greater access to health services and improved coordination of healthcare programmes.

Read More →

U.S. TB infections drop to record low: CDC

U.S. cases of tuberculosis fell 6.4 percent in 2011 to an all-time low, but missed a national target of eliminating the disease as cases among foreign-born individuals persisted, health officials said on Thursday.

Read More →

Top private funder of TB R&D moves forward with trials of promising new drug

Otsuka Pharmaceutical is the top private funder of tuberculosis (TB) research and drug development in the world. Last year, Otsuka established a Geneva-based subsidiary – Otsuka SA – to serve as “the company’s central operations for developing and implementing public health policies and corporate social responsibility programs in connection with its global TB program,” according to the company’s website.

Read More →

Sentinel Project releases moving stories of children with TB

22 March 2012 - New York, NY - The Sentinel Project on Pediatric Drug-Resistant Tuberculosis today launched Being Brave: Stories of Children with Drug-Resistant Tuberculosis today. This collection documents the devastating impact of drug-resistant tuberculosis (DR-TB) on children.

Read More →

Blueprint toward a TB-free future

The following is a guest blog post by Dr. Lucica Ditiu, executive secretary of the Stop TB Partnership, commenting on the newly released document Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade, reflecting the consensus of members of the TB vaccine research and development community to develop new vaccines that could help stop TB in our children’s lifetimes.

Read More →

Page 670 of 717 · Total posts: 10

←First 669 670 671 Last→